AndroGel 1.62% (testosterone gel 1.62%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AndroGel 1.62% (testosterone gel 1.62%), covering 2017-12-07 to 2017-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males [Phase 1]